Heritage Wealth Advisors Has $2.17 Million Position in Johnson & Johnson (JNJ)

Heritage Wealth Advisors increased its position in shares of Johnson & Johnson (NYSE:JNJ) by 6.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 16,663 shares of the company’s stock after acquiring an additional 952 shares during the quarter. Johnson & Johnson makes up approximately 1.1% of Heritage Wealth Advisors’ holdings, making the stock its 17th biggest holding. Heritage Wealth Advisors’ holdings in Johnson & Johnson were worth $2,168,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Landmark Financial Advisors LLC boosted its position in Johnson & Johnson by 0.4% during the second quarter. Landmark Financial Advisors LLC now owns 1,962 shares of the company’s stock worth $259,000 after acquiring an additional 7 shares during the last quarter. Paradigm Financial Advisors LLC boosted its position in Johnson & Johnson by 0.3% during the second quarter. Paradigm Financial Advisors LLC now owns 2,649 shares of the company’s stock worth $350,000 after acquiring an additional 9 shares during the last quarter. Premier Asset Management LLC boosted its holdings in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Premier Asset Management LLC now owns 2,749 shares of the company’s stock valued at $363,000 after purchasing an additional 12 shares during the last quarter. Lbmc Investment Advisors LLC boosted its holdings in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Lbmc Investment Advisors LLC now owns 3,718 shares of the company’s stock valued at $492,000 after purchasing an additional 14 shares during the last quarter. Finally, Halbert Hargrove Russell LLC boosted its holdings in shares of Johnson & Johnson by 0.4% in the 2nd quarter. Halbert Hargrove Russell LLC now owns 3,523 shares of the company’s stock valued at $466,000 after purchasing an additional 15 shares during the last quarter. Hedge funds and other institutional investors own 65.70% of the company’s stock.

Johnson & Johnson (JNJ) opened at $129.53 on Monday. Johnson & Johnson has a one year low of $114.23 and a one year high of $148.32. The company has a quick ratio of 1.02, a current ratio of 1.32 and a debt-to-equity ratio of 0.36. The company has a market cap of $347,980.00, a price-to-earnings ratio of 332.13, a PEG ratio of 2.33 and a beta of 0.74.

Johnson & Johnson (NYSE:JNJ) last issued its earnings results on Tuesday, January 23rd. The company reported $1.74 EPS for the quarter, beating the Zacks’ consensus estimate of $1.72 by $0.02. Johnson & Johnson had a net margin of 1.70% and a return on equity of 27.80%. The business had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.08 billion. During the same quarter last year, the firm posted $1.58 EPS. The business’s revenue for the quarter was up 11.5% compared to the same quarter last year. sell-side analysts forecast that Johnson & Johnson will post 8.08 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Stockholders of record on Tuesday, February 27th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.59%. The ex-dividend date of this dividend is Monday, February 26th. Johnson & Johnson’s dividend payout ratio is presently 861.54%.

A number of equities analysts have weighed in on the stock. Vetr upgraded shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $150.89 price target on the stock in a report on Thursday, January 11th. Citigroup lifted their price target on shares of Johnson & Johnson from $140.00 to $149.00 and gave the company a “buy” rating in a report on Monday, October 23rd. Stifel Nicolaus lifted their price target on shares of Johnson & Johnson from $140.00 to $142.00 and gave the company a “hold” rating in a report on Wednesday, October 18th. Argus lifted their price target on shares of Johnson & Johnson from $145.00 to $165.00 and gave the company a “positive” rating in a report on Wednesday, October 18th. Finally, BMO Capital Markets lifted their price target on shares of Johnson & Johnson to $161.00 and gave the company an “outperform” rating in a report on Tuesday, December 12th. Four analysts have rated the stock with a sell rating, eight have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $146.16.

TRADEMARK VIOLATION NOTICE: “Heritage Wealth Advisors Has $2.17 Million Position in Johnson & Johnson (JNJ)” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/12/heritage-wealth-advisors-has-2-17-million-position-in-johnson-johnson-jnj.html.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply